Contrarian Corpus
activist letter follow up
2018-02-05 · 17 pages

Mellanox Technologies, Ltd. MLNX

Mellanox insiders have sold $130M of stock across 373 trades vs. one purchase since IPO — evidence the Board lacks confidence in its own plan and must be reconstituted.

N 4 Narrative
V 3 Visual
C 3 Craft
Original source ↗

Thesis

Starboard, Mellanox's largest shareholder at 10.7%, argues that the Board and management have sold stock 373 times for ~$130 million since the 2007 IPO — against a single open-market purchase — while delivering the worst three-year TSR in the peer group despite industry-high stock-based compensation. Selling intensified to $4.3 million in the eight weeks after management issued its first-ever annual guidance in December 2017, contradicting Eyal Waldman's Q4 call admission that the team has little short-term visibility. Insider ownership has collapsed from 17.1% in 2008 to 4.9% today, and non-executive directors have sold three times more stock than they currently own. The letter frames this pattern as disqualifying for a board asking shareholders to trust its 2018-2019 growth plan and calls for constructive change.

SCQA

Situation

Mellanox is a semiconductor networking company whose Board and management team have governed since the 2007 IPO, during which Starboard is now the largest shareholder at 10.7% and has filed a 13D.

Complication

Insiders have sold stock 373 times for ~$130M while making a single open-market purchase, ownership has fallen 70%, and selling accelerated right after new guidance — signaling the Board's own lack of confidence.

Resolution

Reconstitute the Board with directors who have genuine skin in the game, end the one-sided selling pattern, and engage constructively with Starboard on a plan to create long-term shareholder value.

Reward

If insiders had held their shares, aggregate value would be >$110M higher today; a Board truly committed to Mellanox is a prerequisite for closing the persistent TSR gap versus semiconductor peers.

The three reasons

  1. 1

    Insiders made 373 open-market sales for ~$130M since 2007 vs. a single open-market purchase

  2. 2

    Selling intensified to $4.3M in 8 weeks right after December 2017 guidance release

  3. 3

    Mellanox has lowest 3-year TSR among peers yet industry-high stock-based comp

Primary demands

  • Board and management must stop the one-sided pattern of insider selling and demonstrate alignment with shareholders
  • Reconstitute the Board to include directors with meaningful skin in the game
  • Engage constructively with Starboard to position Mellanox for long-term success

KPIs cited

Insider open-market sales since IPO
373 sales totaling ~$130M ($129,286,393)
Insider open-market purchases since IPO
1 purchase of $1,999,969 (Baharav Dov, Nov 2013)
Average insider sale price
~$34/share, roughly 50% below current stock price
Value left on the table by insider selling
>$110M vs. if shares had been held
Recent insider selling
>$4.3M sold in 8 weeks following December 2017 guidance
Insider ownership decline
From 17.1% (2008) to 4.9% (current) — a 70% decline
3-Year TSR vs. peers
Lowest in peer group in three years prior to Starboard's Nov 2017 13D
LTM Stock-Based Compensation
~8% of revenue, among the highest in peer group
Non-executive director stock sales vs. holdings
$54.5M proceeds from sales vs. $17.4M current ownership

Pattern membership

Where this document fits across the library's 12 rhetorical / structural patterns.

Notable slides (5)

Notes

Open letter from Peter A. Feld (Managing Member, Starboard) to Chairman Irwin Federer, cc'd to CEO Eyal Waldman and other directors. Filed as an exhibit to DFAN14A proxy materials. The argument is built entirely around insider-selling behavior as a governance signal: 373 sales vs. 1 purchase is the signature framing. Embeds a direct Waldman Q4 2017 earnings-call quote admitting low visibility as contradiction to the 2018-2019 guidance. Peer-gap scatterplot (SBC % of revenue vs. 3-Year TSR) highlights MLNX as the clear outlier. Pages 7-17 are a dense BamSEC-style appendix listing every individual insider transaction. This is a follow-up to the 11/20/2017 13D, not the initial thesis.